104 related articles for article (PubMed ID: 23542037)
1. HDAC inhibitors prevent the induction of the immediate-early gene FOSL1, but do not alter the nucleosome response.
Khan DH; Davie JR
FEBS Lett; 2013 May; 587(10):1510-7. PubMed ID: 23542037
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of histone deacetylation by trichostatin A intensifies the transcriptions of neuronal c-fos and c-jun genes after kainate stimulation.
Sng JC; Taniura H; Yoneda Y
Neurosci Lett; 2005 Oct; 386(3):150-5. PubMed ID: 16002216
[TBL] [Abstract][Full Text] [Related]
3. Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2.
Icardi L; Lievens S; Mori R; Piessevaux J; De Cauwer L; De Bosscher K; Tavernier J
FASEB J; 2012 Jan; 26(1):240-9. PubMed ID: 21957129
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors.
Koppel I; Timmusk T
Neuropharmacology; 2013 Dec; 75():106-15. PubMed ID: 23916482
[TBL] [Abstract][Full Text] [Related]
5. Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation.
Clayton AL; Rose S; Barratt MJ; Mahadevan LC
EMBO J; 2000 Jul; 19(14):3714-26. PubMed ID: 10899125
[TBL] [Abstract][Full Text] [Related]
6. Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3.
Pufahl L; Katryniok C; Schnur N; Sorg BL; Metzner J; Grez M; Steinhilber D
J Cell Mol Med; 2012 Jul; 16(7):1461-73. PubMed ID: 21883892
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of histone deacetylases protects septic mice from lung and splenic apoptosis.
Takebe M; Oishi H; Taguchi K; Aoki Y; Takashina M; Tomita K; Yokoo H; Takano Y; Yamazaki M; Hattori Y
J Surg Res; 2014 Apr; 187(2):559-70. PubMed ID: 24290430
[TBL] [Abstract][Full Text] [Related]
8. Plakoglobin is a new target gene of histone deacetylase in human fibrosarcoma HT1080 cells.
Shim JS; Kim DH; Kwon HJ
Oncogene; 2004 Mar; 23(9):1704-11. PubMed ID: 14661058
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression.
Young DA; Billingham O; Sampieri CL; Edwards DR; Clark IM
FEBS J; 2005 Apr; 272(8):1912-26. PubMed ID: 15819885
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury.
Marumo T; Hishikawa K; Yoshikawa M; Hirahashi J; Kawachi S; Fujita T
Am J Physiol Renal Physiol; 2010 Jan; 298(1):F133-41. PubMed ID: 19906951
[TBL] [Abstract][Full Text] [Related]
11. Targeting histone deacetylases: development of vorinostat for the treatment of cancer.
Richon VM
Epigenomics; 2010 Jun; 2(3):457-65. PubMed ID: 22121904
[TBL] [Abstract][Full Text] [Related]
12. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.
Lin YC; Lin JH; Chou CW; Chang YF; Yeh SH; Chen CC
Cancer Res; 2008 Apr; 68(7):2375-83. PubMed ID: 18381445
[TBL] [Abstract][Full Text] [Related]
13. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
Zhao S; Venkatasubbarao K; Li S; Freeman JW
Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
[TBL] [Abstract][Full Text] [Related]
14. How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot.
Beyer M; Kiweler N; Mahboobi S; Krämer OH
Methods Mol Biol; 2017; 1510():355-364. PubMed ID: 27761834
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of HDAC inhibitor-induced thrombocytopenia.
Matsuoka H; Unami A; Fujimura T; Noto T; Takata Y; Yoshizawa K; Mori H; Aramori I; Mutoh S
Eur J Pharmacol; 2007 Oct; 571(2-3):88-96. PubMed ID: 17628529
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase activity is required for the induction of the MyoD muscle cell lineage in Xenopus.
Steinbac OC; Wolffe AP; Rupp RA
Biol Chem; 2000; 381(9-10):1013-6. PubMed ID: 11076034
[TBL] [Abstract][Full Text] [Related]
17. Role for Class I histone deacetylases in multidrug resistance.
Xu Y; Jiang Z; Yin P; Li Q; Liu J
Exp Cell Res; 2012 Feb; 318(3):177-86. PubMed ID: 22154511
[TBL] [Abstract][Full Text] [Related]
18. Activation of the mouse histone deacetylase 1 gene by cooperative histone phosphorylation and acetylation.
Hauser C; Schuettengruber B; Bartl S; Lagger G; Seiser C
Mol Cell Biol; 2002 Nov; 22(22):7820-30. PubMed ID: 12391151
[TBL] [Abstract][Full Text] [Related]
19. Independent dynamic regulation of histone phosphorylation and acetylation during immediate-early gene induction.
Thomson S; Clayton AL; Mahadevan LC
Mol Cell; 2001 Dec; 8(6):1231-41. PubMed ID: 11779499
[TBL] [Abstract][Full Text] [Related]
20. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
Lee SH; Kim J; Kim WH; Lee YM
Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
